DOJ to Receive Public Comments on Cannabis Reclassification Throuh July 22
The U.S. Department of Justice (DOJ) is set to begin accepting comments on a rule that would move marijuana to a lower drug classification. This historic move comes after the U.S. Department of Health and Human Services recommended that the drug be rescheduled following a directive issued by President Biden in 2022 to review the drug’s current classification. At the moment, marijuana is classified as a Schedule I drug under the Controlled Substances Act. Drugs under this classification are said to have no accepted use in the medical world and a high potential for abuse. The drugs include heroin, LSD,…